MoonLake Immunotherapeutics Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
MoonLake Immunotherapeutics quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2024.
  • MoonLake Immunotherapeutics Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.56 USD/shares, a 211% decline year-over-year.
  • MoonLake Immunotherapeutics Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.26 USD/shares, a 188% decline year-over-year.
  • MoonLake Immunotherapeutics annual Earnings Per Share, Basic for 2023 was -0.73 USD/shares, a 57.1% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1 -$1 $0 -211% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$1 $0 $0 -69.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$1 $0 +$0.01 +4.35% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$1 $0 -$2 -104% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.44 $0 +$0.09 +33.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $1.35 $0 +$0.11 +32.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.24 $0 +$2.94 +92.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$2 $2.08 Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $0 +$2.36 +89.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $0 +$2.56 +88.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$3 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$3 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.